Specialty Pharmacy

September 16th 2024

With the introduction of expensive drugs and associated challenges for hospital budgets, pharmacy leaders benefit from strategically managing financial, clinical, and regulatory factors for sustainable care delivery.

September 13th 2024

The approval marks the first and only twice yearly, health care professional-administrated injection for both forms of multiple sclerosis (MS).

September 13th 2024

These results build off the PURPOSE 1 trial, contributing to the wealth of evidence surrounding lenacapavir’s positive effects in patients with HIV.

September 12th 2024

Investigators obtained real-world evidence to evaluate the clinical outcomes of non-medical switching from the infliximab (Remicade; Janssen Immunology) to a biosimilar.